Inherited phaeochromocytoma and paraganglioma excluding NF1: genes and variants
Explore variant evidence for Inherited phaeochromocytoma and paraganglioma excluding NF1 across 5 analyzed proteins (SDHB, VHL, SDHC, SDHA, FH). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 4 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Inherited phaeochromocytoma and paraganglioma excluding NF1
SDHB: Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
It transfers electrons from succinate oxidation through iron-sulfur centers toward ubiquinone in mitochondrial complex II. Heterozygous loss-of-function variants strongly predispose to paraganglioma and pheochromocytoma and can also increase renal-tumor and gastrointestinal-stromal-tumor risk.
4 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SDHB have source records linked to Inherited phaeochromocytoma and paraganglioma excluding NF1. Association strength is not clinical gene validity.
VHL: von Hippel-Lindau disease tumor suppressor
It targets hydroxylated HIF-alpha proteins for ubiquitin-mediated degradation when oxygen is sufficient, keeping hypoxia-response programs suppressed. Loss of function stabilizes HIF signaling and causes von Hippel-Lindau tumor-predisposition syndrome while also driving most clear-cell renal carcinomas.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in VHL have source records linked to Inherited phaeochromocytoma and paraganglioma excluding NF1. Association strength is not clinical gene validity.
SDHC: Succinate dehydrogenase cytochrome b560 subunit, mitochondrial
It anchors succinate dehydrogenase to the inner mitochondrial membrane and helps transfer electrons from the catalytic subunits to ubiquinone. Heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and some gastrointestinal stromal tumors.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SDHC have source records linked to Inherited phaeochromocytoma and paraganglioma excluding NF1. Association strength is not clinical gene validity.
SDHA: Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
It catalyzes oxidation of succinate to fumarate while transferring electrons into respiratory-chain complex II, directly linking the TCA cycle with oxidative phosphorylation. Biallelic deficiency can cause mitochondrial disease, while heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and selected gastrointestinal stromal tumors.
1 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in SDHA have source records linked to Inherited phaeochromocytoma and paraganglioma excluding NF1. Association strength is not clinical gene validity.
FH: Fumarate hydratase, mitochondrial
It converts fumarate to malate in the mitochondrial TCA cycle. Biallelic loss causes fumarase deficiency, while heterozygous loss-of-function variants cause hereditary leiomyomatosis and renal cell cancer syndrome through fumarate accumulation and tumor-suppressor loss.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in FH have source records linked to Inherited phaeochromocytoma and paraganglioma excluding NF1. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SDHAF2 and SDHD.
ClinVar pathogenic and likely pathogenic variants linked to Inherited phaeochromocytoma and paraganglioma excluding NF1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SDHB K40E | 40 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB G96S | 96 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHC Y126C | 126 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC H127R | 127 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHA R589W | 589 | Pathogenic / likely pathogenic (★★) | |
| FH F312L | 312 | Pathogenic / likely pathogenic (★★) | |
| SDHB C98R | 98 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| VHL R161Q | 161 | Interaction with Elongin BC complex | Pathogenic / likely pathogenic (★★) |
| VHL P81L | 81 | Pathogenic / likely pathogenic (★★) | |
| SDHB N104S | 104 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Inherited phaeochromocytoma and paraganglioma excluding NF1
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 93 out of 100
- AlphaMissense: 93 out of 100
- SIFT: 92 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 88 out of 100
- phyloP: 85 out of 100
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 63 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 39 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (53 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (48 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (47 pathogenic / likely pathogenic).
- Carney-Stratakis syndrome also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (7 pathogenic / likely pathogenic).
- Mitochondrial complex 2 deficiency, nuclear also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (7 pathogenic / likely pathogenic).
- Von Hippel-Lindau disease also has ClinVar records linked to VHL variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (147 pathogenic / likely pathogenic).
- Chuvash polycythemia also has ClinVar records linked to VHL variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (116 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to VHL variants; they fall partly in the same places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (4 pathogenic / likely pathogenic).
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHC variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (16 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHC variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (16 pathogenic / likely pathogenic).
- Mitochondrial complex II deficiency, nuclear also has ClinVar records linked to SDHA variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (18 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHA variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (14 pathogenic / likely pathogenic).
- Neurodegeneration with ataxia and late-onset optic atrophy also has ClinVar records linked to SDHA variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (5 pathogenic / likely pathogenic).
- Hereditary leiomyomatosis and renal cell cancer also has ClinVar records linked to FH variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (34 pathogenic / likely pathogenic).
- Fumaric aciduria also has ClinVar records linked to FH variants; they fall mostly in different places as the Inherited phaeochromocytoma and paraganglioma excluding NF1 variants (11 pathogenic / likely pathogenic).
Diseases related to Inherited phaeochromocytoma and paraganglioma excluding NF1
- Gastrointestinal stromal tumor, also linked to SDHA, SDHB and SDHC
- Pheochromocytoma/paraganglioma syndrome, also linked to SDHA, SDHB and SDHC
- Hereditary pheochromocytoma and paraganglioma, also linked to SDHA, SDHB and SDHC
- Pheochromocytoma, also linked to SDHB and VHL
- Carney-Stratakis syndrome, also linked to SDHB and SDHC
- Von Hippel-Lindau disease, also linked to VHL
- Chuvash polycythemia, also linked to VHL
- Ovarian cancer, also linked to FH
- Hereditary leiomyomatosis and renal cell cancer, also linked to FH
- Mitochondrial complex II deficiency, nuclear, also linked to SDHA
- Fumaric aciduria, also linked to FH
- Mitochondrial complex 2 deficiency, nuclear, also linked to SDHB
Frequently asked questions
Which genes have records linked to Inherited phaeochromocytoma and paraganglioma excluding NF1?
This view contains 5 analyzed proteins: SDHB, VHL, SDHC, SDHA, FH. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 4 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 16 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center